Drug Discovery World

FEBRUARY 28, 2023

Three hundred and fifty million people in the world, with 37 million in the United States and Canada, have been diagnosed with rare disease, 80% of which are inherited and genetic in origin 2. Therefore, the risk for off-target insertional mutagenesis is greatly reduced.

Genetics 52

Genetics Genetic Analysis Vaccination Vaccine 52

XTalks

MARCH 7, 2024

Research at SRI International has highlighted the relationship between hormonal changes and sleep disruptions and developed systems to manage hot flashes. Addressing women’s health issues on this day also underscores the critical link between women’s health and broader socio-economic development.

Hormones 115

Hormones Genetics Genome Genomics 115

Drug Discovery World

APRIL 21, 2023

Meanwhile, Curiox Biosystems is enabling accurate biological analysis through automation. BMG LABTECH develops and manufactures innovative, high- quality, and reliable microplate reader instrumentation, while Microtechnix (MTX) is a company providing innovative solutions for biological laboratory assays. It will be led by Björn C.

Doctors 52

Doctors Doctor Genetics In-Vitro 52

Drug Discovery World

MARCH 2, 2023

DDW’s Diana Spencer reports on the recent Avacta Therapeutics Science Day, which explored the latest exciting developments in targeted treatments for cancer and asked what advances the future might bring. She explained the mechanism by which AVA6000 can provide more precise treatment than current chemotherapies.

Trials 52

Trials Development Genetic Analysis Drugs 52

Drug Discovery World

DECEMBER 14, 2023

Early operations focused on the discovery of green fluorescent protein (GFP), which played a very big role in early drug discovery research operations using cellular assays. But it comes with surface charge that will absorb proteins, DNA, and other things, unless you do something to treat that surface.

Drugs 52

Drugs Production Protein Genetic Analysis 52

Drug Discovery World

JUNE 14, 2023

BCA members also operate the BCA Advanced Therapies Network which is a diverse, fully integrated portfolio of blood, cell, gene and tissue materials that support the development and delivery of advanced therapies. BCA and its members are developing innovative ways to attract younger donors through the use of technology.

Manufacturing 52

Manufacturing Production Gene Therapy Development 52

XTalks

DECEMBER 15, 2020

Plant proteins , milk alternatives , meat alternatives , bee-less honey , lab-grown meat and more are all kinds of innovations we have seen in 2020, but studies show that plant-based trends are still on the rise as new technologies are developed to cater to this market. 4. Technology.

Production 98

Production Manufacturing Marketing Sales 98